Leverage Analysis Stories
Will Nio (USA Stocks:NIO) continue to grow in January?
![]() | 23 hours ago at Macroaxis By Ellen Johnson |
Investing in NIO's Class A stock presents an intriguing case from a leverage standpoint, especially considering the company's recent financial data. With a substantial 19.9B in cash and equivalents, NIO appears to have a robust financial cushion to support its operations and investment strategies. However, potential investors must also weigh the company's significant operating loss of 15.6B, which raises questions about its current profitability and cost management. Continue Reading...
- NIO Nio Class A
- Latest Will Nio continue to grow in January
- NIO 7.43 0.11
- Low 7.38
- High 7.96
- Volume 87.9 M
- Alpha -0.48
- Beta 2.44
- Return On Equity -0.78
- Return On Asset -0.15
- Profit Margin (0.43) %
- Operating Margin (0.69) %
- Current Valuation 16.42 B
- Shares Outstanding 1.78 B
- Shares Owned By Insiders 7.85 %
- Shares Owned By Institutions 33.84 %
- Number Of Shares Shorted 140.39 M
- Price To Earning 10.16 X
- Price To Book 6.25 X
- Price To Sales 0.27 X
- Revenue 49.27 B
- Gross Profit 5.14 B
- EBITDA (14.19 B)
- Net Income (14.44 B)
- Cash And Equivalents 19.89 B
- Cash Per Share 27.32 X
- Total Debt 23.71 B
- Debt To Equity 0.82 %
- Current Ratio 1.59 X
- Book Value Per Share 8.66 X
- Cash Flow From Operations (3.87 B)
- Short Ratio 4.38 X
- Earnings Per Share (1.79) X
- Price To Earnings To Growth 801.07 X
- Target Price 15.21
- Number Of Employees 26.76 K
- Beta 1.99
- Market Capitalization 13.17 B
- Total Asset 96.26 B
- Retained Earnings (69.91 B)
- Working Capital 13.3 B
- Current Asset 4.65 B
- Current Liabilities 2.55 B
- Z Score -0.49
- Net Asset 96.26 B
- Accumulation Distribution 6.4 M
- Daily Balance Of Power 0.1897
- Rate Of Daily Change 1.02
- Day Median Price 7.67
- Day Typical Price 7.59
- Price Action Indicator (0.19)
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
In the world of finance, what goes up must be scrutinized. Arrowmark Financial Corp, operating in the bustling asset management sector within the financial services category, presents a mixed bag of indicators that could signal impending volatility. With a total liability of **$60.8M** and a net debt position of **$55.2M**, the company's leverage is a critical factor for investors to consider.
a day ago at Macroaxis By Vlad Skutelnik | ![]() |
Buy low, sell high. That's the age-old adage in investing. However, for Aesthetic Medical International (AIH), a player in the Healthcare sector specifically under Health Care Providers & Services, it might be time to reconsider this principle.
over a week ago at Macroaxis By Rifka Kats | ![]() |
GreenTree Hospitality Group carries a debt of 2.06 billion, with a debt-to-equity (D/E) ratio of 0.35. This ratio is acceptable within its current industry classification. The company's current ratio stands at 1.44, which is standard for the industry and is considered normal.
over a week ago at Macroaxis By Ellen Johnson | ![]() |
Ideanomics, a software service company listed on NASDAQ, has shown significant financial growth with an increase in cash flow from **165.8M** to **269.9M**. This growth is largely attributed to the total cash from financing activities amounting to **399.3M**. The company's total assets stand at **473.4M**, including intangible assets worth 42.5M and property, plant, and equipment net valued at 15.7M.
over two weeks ago at Macroaxis By Aina Ster | ![]() |
In the world of investing, the saying goes, "no risk, no reward." This certainly rings true for Orchard Therapeutics PLC (USA Stocks: ORTX), a biotechnology firm in the healthcare sector. Despite the company's current debt obligations, including short term debt of $15.9M and capital lease obligations of $25.7M, it remains a promising investment opportunity. The company's cash position stands at a robust $68.4M, offering a safety net against its financial obligations.
over three weeks ago at Macroaxis By Gabriel Shpitalnik | ![]() |
Every cloud has a silver lining, and in the case of Four Seasons Education (USA Stocks:FEDU), a diversified consumer services company in the education and training services industry, this adage might just hold true. Despite the company's significant loss of $33.5M and total liabilities amounting to $89.2M, it's important to note that Four Seasons Education has a robust net working capital of $423.8M and cash and short-term investments totaling a whopping $491.9M. This financial cushion could potentially offset its current debt obligations, making the idea of liquidating the company's stock a decision that requires careful consideration.
over a month ago at Macroaxis By Nico Santiago | ![]() |
Comerica, a leading player in the Financial Services sector, has shown promising signs of sustainable growth. The company, traded on the NYSE, boasts a robust total stockholder equity of $5.2B and an impressive net interest income of $2.5B. Despite a loss of $376M in dividends paid, Comerica has managed to maintain a forward dividend yield of 0.0676, which is mirrored in its dividend yield.
over a month ago at Macroaxis By Aina Ster | ![]() |
Investors considering a position in Cal-Maine Foods (NASDAQ: CALM) should note the company's relatively low debt levels, which provide a strong foundation for future growth. With total liabilities of only 344.9 million, the company's balance sheet appears healthy, especially when compared to its net invested capital of 1.6 billion. This low debt level gives Cal-Maine Foods significant financial flexibility, allowing it to invest in growth opportunities or weather potential downturns.
over two months ago at Macroaxis By Aina Ster | ![]() |
Herbalife Nutrition, a prominent player in the Personal Care Products industry, has shown some intriguing financial dynamics as we head into October. Despite a significant Retained Earnings loss of 1.2B, the company's Total Revenue stands strong at 5.2B, outpacing the Cost Of Revenue of 1.2B. The company's End Period Cash Flow is also robust at 516.3M, supporting a healthy Free Cash Flow of 196.1M.
over two months ago at Macroaxis By Gabriel Shpitalnik | ![]() |